RADIATION MODULATES THE PEPTIDE REPERTOIRE, ENHANCING MHC CLASS I EXPRESSION AND IMPROVING ANTI-TUMOR IMMUNO-THERAPY

被引：0
|
作者：
Neefjes, J. [1 ]
Qiao, X. [1 ]
Pang, B. [1 ]
机构：
[1] NKI AVL, Tumor Biol, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
509
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [21] Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects
    Miura, Naoya
    Akita, Hidetaka
    Tateshita, Naho
    Nakamura, Takashi
    Harashima, Hideyoshi
    MOLECULAR THERAPY, 2017, 25 (04) : 1003 - 1013
  • [22] Analysis of the tumor reactivity of tumor-infiltrating lymphocytes in a metastatic melanoma lesion that lost MHC class I expression after anti-PD-1 therapy
    Inozume, T.
    Yaguchi, T.
    Ariyasu, R.
    Togashi, Y.
    Nishikawa, H.
    Kawakami, Y.
    Kawamura, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S134 - S134
  • [23] Vesicular stomatitis virus expressing destabilized tumor associated antigens with enhanced MHC class I presentation to improve anti-tumor T cell responses
    Huff, Amanda
    Evgin, Laura
    Thompson, Jill
    Kottke, Tim
    Wongthida, Phonphimon
    Driscoll, Christopher
    Shim, Kevin G.
    Scheulke, Matthew
    Vile, Richard G.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [24] Gene therapy increases MHC class-I and T cell Infiltration to promote anti-tumor immune response in 4T1 breast cancer model
    Shi, Guilan
    Heller, Richard
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [25] Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells
    Oh, D. S.
    Lee, H. K.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 4 - 4
  • [26] Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells
    Oh, Dong Sun
    Lee, Heung Kyu
    AUTOPHAGY, 2019, 15 (12) : 2091 - 2106
  • [27] MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer
    Poli, Caroline
    Raffin, Caroline
    Dojcinovic, Danijel
    Luescher, Immanuel
    Ayyoub, Maha
    Valmori, Danila
    HAEMATOLOGICA, 2013, 98 (02) : 316 - 322
  • [28] MHC class I-restricted tumor epitope specific TCR engineered CD4+ T cells function as helper and cytolytic effector cells in anti-tumor immunity
    Chhabra, Arvind
    Yang, Lili
    Wang, Pin
    Chakraborty, Nitya G.
    Das, Raja
    Ribas, Antoni
    Kohn, Donald
    Baltimore, David
    Economou, James
    Mukherji, Bijay
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 899 - 899
  • [29] REGULATED EXPRESSION OF TUMOR-SPECIFIC AND MHC CLASS-I ANTIGENS IN AN ULTRAVIOLET RADIATION-INDUCED MURINE SKIN-CANCER
    ANANTHASWAMY, HN
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 90 (03) : 263 - 266
  • [30] Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4(+) anti-tumor T cells requires tumor expression of cell surface MHC class II molecules
    Frey, AB
    Cestari, S
    CELLULAR IMMUNOLOGY, 1997, 178 (01) : 79 - 90
12345